These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 23523147)

  • 1. Quantitative measures of visceral adiposity and body mass index in predicting rectal cancer outcomes after neoadjuvant chemoradiation.
    Clark W; Siegel EM; Chen YA; Zhao X; Parsons CM; Hernandez JM; Weber J; Thareja S; Choi J; Shibata D
    J Am Coll Surg; 2013 Jun; 216(6):1070-81. PubMed ID: 23523147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher visceral fat area/subcutaneous fat area ratio measured by computed tomography is associated with recurrence and poor survival in patients with mid and low rectal cancers.
    Lee KH; Kang BK; Ahn BK
    Int J Colorectal Dis; 2018 Sep; 33(9):1303-1307. PubMed ID: 29713823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral-to-subcutaneous fat ratio exhibits strongest association with early post-operative outcomes in patients undergoing surgery for advanced rectal cancer.
    Bocca G; Mastoridis S; Yeung T; James DRC; Cunningham C
    Int J Colorectal Dis; 2022 Aug; 37(8):1893-1900. PubMed ID: 35902393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semiautomated Measure of Abdominal Adiposity Using Computed Tomography Scan Analysis.
    Srikumar T; Siegel EM; Gu Y; Balagurunathan Y; Garcia AL; Chen YA; Zhou JM; Zhao X; Gillies R; Clark W; Gamenthaler A; Choi J; Shibata D
    J Surg Res; 2019 May; 237():12-21. PubMed ID: 30694786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients.
    Belluco C; Forlin M; Delrio P; Rega D; Degiuli M; Sofia S; Olivieri M; Pucciarelli S; Zuin M; De Manzoni G; Di Leo A; Scabini S; Zorcolo L; Restivo A
    BMC Cancer; 2018 Nov; 18(1):1094. PubMed ID: 30419864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral obesity and colorectal cancer: are we missing the boat with BMI?
    Rickles AS; Iannuzzi JC; Mironov O; Deeb AP; Sharma A; Fleming FJ; Monson JR
    J Gastrointest Surg; 2013 Jan; 17(1):133-43; discussion p.143. PubMed ID: 23090279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between DXA-based and anthropometric measures of visceral fat and morbidity in women.
    Direk K; Cecelja M; Astle W; Chowienczyk P; Spector TD; Falchi M; Andrew T
    BMC Cardiovasc Disord; 2013 Apr; 13():25. PubMed ID: 23552273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncologic and Functional Hazards of Obesity Among Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiation Therapy.
    Park IJ; You YN; Skibber JM; Rodriguez-Bigas MA; Das P; Eng C; Kopetz S; Wolff RA; Crane CH; Krishnan S; Minsky B; Hu CY; Nguyen S; Chang GJ
    Am J Clin Oncol; 2017 Jun; 40(3):277-282. PubMed ID: 27028350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral obesity is associated with outcomes of total mesorectal excision for rectal adenocarcinoma.
    Ballian N; Lubner MG; Munoz A; Harms BA; Heise CP; Foley EF; Kennedy GD
    J Surg Oncol; 2012 Mar; 105(4):365-70. PubMed ID: 21751219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative computed tomography measurements of pancreatic steatosis and visceral fat: prognostic markers for dissemination and lethality of pancreatic adenocarcinoma.
    Mathur A; Hernandez J; Shaheen F; Shroff M; Dahal S; Morton C; Farrior T; Kedar R; Rosemurgy A
    HPB (Oxford); 2011 Jun; 13(6):404-10. PubMed ID: 21609373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Assessment of Visceral Obesity and Postoperative Colon Cancer Outcomes.
    Ozoya OO; Siegel EM; Srikumar T; Bloomer AM; DeRenzis A; Shibata D
    J Gastrointest Surg; 2017 Mar; 21(3):534-542. PubMed ID: 28101721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abdominal adiposity, body composition and survival after liver transplantation.
    Terjimanian MN; Harbaugh CM; Hussain A; Olugbade KO; Waits SA; Wang SC; Sonnenday CJ; Englesbe MJ
    Clin Transplant; 2016 Mar; 30(3):289-94. PubMed ID: 26717257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body fat distribution is more predictive of all-cause mortality than overall adiposity.
    Lee SW; Son JY; Kim JM; Hwang SS; Han JS; Heo NJ
    Diabetes Obes Metab; 2018 Jan; 20(1):141-147. PubMed ID: 28671751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilizing quantitative measures of visceral adiposity in evaluating trauma patient outcomes.
    Docimo S; Lamparello B; Cohen MF; Kopatsis A; Vinces F
    Int J Surg; 2015 Sep; 21():51-6. PubMed ID: 26166742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer.
    Carruthers R; Tho LM; Brown J; Kakumanu S; McCartney E; McDonald AC
    Colorectal Dis; 2012 Oct; 14(10):e701-7. PubMed ID: 22731833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditional Probability of Survival After Neoadjuvant Chemoradiation and Proctectomy for Rectal Cancer: What Matters and When.
    Karagkounis G; Liska D; Kalady MF
    Dis Colon Rectum; 2019 Jan; 62(1):33-39. PubMed ID: 30451761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin therapy is associated with improved pathologic response to neoadjuvant chemoradiation in rectal cancer.
    Mace AG; Gantt GA; Skacel M; Pai R; Hammel JP; Kalady MF
    Dis Colon Rectum; 2013 Nov; 56(11):1217-27. PubMed ID: 24104995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Delaying Surgical Resection After Neoadjuvant Chemoradiation Impact Clinical Outcomes in Locally Advanced Rectal Adenocarcinoma?: A Single-Institution Experience.
    Nguyen P; Wuthrick E; Chablani P; Robinson A; Simmons L; Wu C; Arnold M; Harzman AE; Husain S; Schmidt C; Abdel-Misih S; Bekaii-Saab T; Chakravarti A; Williams TM
    Am J Clin Oncol; 2018 Feb; 41(2):140-146. PubMed ID: 26535992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.